Trial intelligence / Profile preview

Probiotic and Zinc Supplementations in Pediatric Ventriculitis

NCT06151392Phase 4Completed

Sponsor
Ain Shams University
Start
Jul 2023
Primary completion
Jul 2026
Modality
Small Molecules, Yeast Strains, Defined Consortia
Countries
1
01

Overview

Phase 4, randomised, open-label trial of zinc in ventriculitis (4 arms), sponsored by Ain Shams University. Primary endpoints: Cerebrospinal Fluid culture at 14 days, Normalization of the Cerebrospinal Fluid chemistry at 14 days and 1 more. Started Jul 2023; status: completed.

02

Drugs

zinc
03

Conditions

ventriculitis

Beyond the preview

Go deeper on NCT06151392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06151392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call